Graphene oxide nanosheets (GO) were reported to alter neurobio- logical processes involving cell membrane dynamics. GO ability to reversibly downregulate specifically glutamatergic synapses under- pins their potential in future neurotherapeutic developments. Aberrant glutamate plasticity contributes to stress-related psycho- pathology and drugs which target dysregulated glutamate rep- resent promising treatments. We find that in a rat model of post- traumatic stress disorder (PTSD), a single injection of GO to the lateral amygdala following the stressful event induced PTSD- related behavior remission and reduced dendritic spine densities. We explored from a mechanistic perspective how GO could impair glutamate synaptic plasticity. By simultaneous patch clamp pair recordings of unitary synaptic currents, live-imaging of presynaptic vesicle release and confocal microscopy, we report that GO nanosheets altered the probability of release enhancing the extinc- tion of synaptic plasticity in the amygdala. These findings show that the modulation of presynaptic glutamate release might rep- resent an unexplored target for (nano)pharmacological interven- tions of stress-related disorders.

Delivery of graphene oxide nanosheets modulates glutamate release and normalizes amygdala synaptic plasticity to improve anxiety-related behavior / Pati, Elisa; FRANCESCHI BIAGIONI, Audrey; Casani, Raffaele; Lozano, Neus; Kostarelos, Kostas; Cellot, Giada; Ballerini, Laura. - In: NANOSCALE. - ISSN 2040-3364. - (2023). [10.1039/d3nr04490d]

Delivery of graphene oxide nanosheets modulates glutamate release and normalizes amygdala synaptic plasticity to improve anxiety-related behavior

Elisa Pati;Audrey Franceschi Biagioni;Raffaele Casani;Giada Cellot
;
Laura Ballerini
2023-01-01

Abstract

Graphene oxide nanosheets (GO) were reported to alter neurobio- logical processes involving cell membrane dynamics. GO ability to reversibly downregulate specifically glutamatergic synapses under- pins their potential in future neurotherapeutic developments. Aberrant glutamate plasticity contributes to stress-related psycho- pathology and drugs which target dysregulated glutamate rep- resent promising treatments. We find that in a rat model of post- traumatic stress disorder (PTSD), a single injection of GO to the lateral amygdala following the stressful event induced PTSD- related behavior remission and reduced dendritic spine densities. We explored from a mechanistic perspective how GO could impair glutamate synaptic plasticity. By simultaneous patch clamp pair recordings of unitary synaptic currents, live-imaging of presynaptic vesicle release and confocal microscopy, we report that GO nanosheets altered the probability of release enhancing the extinc- tion of synaptic plasticity in the amygdala. These findings show that the modulation of presynaptic glutamate release might rep- resent an unexplored target for (nano)pharmacological interven- tions of stress-related disorders.
2023
10.1039/d3nr04490d
https://pubmed.ncbi.nlm.nih.gov/37955642/
Pati, Elisa; FRANCESCHI BIAGIONI, Audrey; Casani, Raffaele; Lozano, Neus; Kostarelos, Kostas; Cellot, Giada; Ballerini, Laura
File in questo prodotto:
File Dimensione Formato  
2023_Nanoscale.pdf

accesso aperto

Descrizione: pdf editoriale
Tipologia: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 2.23 MB
Formato Adobe PDF
2.23 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11767/134830
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact